<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19536" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chronic Pain</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dydyk</surname>
            <given-names>Alexander M.</given-names>
          </name>
          <aff>Abrazo Central Campus</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Conermann</surname>
            <given-names>Till</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Alexander Dydyk declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Till Conermann declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19536.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chronic pain affects over one-quarter of the&#x000a0;United States population and is a prevalent complaint seen in outpatient medical clinics. The condition encompasses a wide range of persistent discomfort lasting beyond&#x000a0;3 to&#x000a0;6 months and often originates from various sources, including injury, disease, or unknown causes. Chronic pain can significantly impair an individual's quality of life, leading to physical limitations, emotional distress, and social isolation. Moreover, the failure to diagnose and effectively manage chronic pain can contribute to opioid use disorders and increase morbidity and mortality rates among affected individuals. Therefore, healthcare professionals must understand chronic pain and implement appropriate treatment strategies.</p>
        <p>This activity provides healthcare professionals with a comprehensive understanding of chronic pain, including its evaluation and treatment modalities. Participants explore the multifaceted nature of chronic pain, including the underlying mechanisms, assessment tools, and evidence-based interventions. The course also emphasizes the importance of an integrated approach to chronic pain management, highlighting the role of the healthcare team in providing holistic care to patients. By enhancing knowledge and skills in chronic pain management, participants are better equipped to address the complex needs of patients in pain and improve outcomes in clinical practice.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between acute and chronic pain and nociceptive and neuropathic pain mechanisms.</p></list-item><list-item><p>Select the appropriate methodology to identify chronic pain, characterize chronic pain, and differentiate the types of chronic pain.&#x000a0;</p></list-item><list-item><p>Apply pharmacological and non-pharmacological interventions appropriately in the management of chronic pain.</p></list-item><list-item><p>Collaborate with interdisciplinary team members, including pain specialists, psychologists, and physical therapists, to optimize patient care.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19536&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19536">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19536.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Over one-quarter of people in the United States (US) suffer from chronic pain&#x02014;one of the most prevalent issues&#x000a0;encountered in&#x000a0;outpatient medical settings.<xref ref-type="bibr" rid="article-19536.r1">[1]</xref>&#x000a0;However, inadequate management of chronic pain and the subsequent reliance on opioids contribute significantly to&#x000a0;morbidity and mortality.&#x000a0;Most patient visits in outpatient clinics&#x000a0;are prompted&#x000a0;by pain-related concerns, with over half&#x000a0;seeking relief from&#x000a0;their primary care provider.&#x000a0;Hence, primary care providers must comprehensively understand chronic pain management.&#x000a0;The US&#x000a0;spends well over 100 billion dollars&#x000a0;annually on healthcare&#x000a0;expenses&#x000a0;associated with pain management and opioid use disorders.<xref ref-type="bibr" rid="article-19536.r2">[2]</xref>&#x000a0;This surpasses the combined expenses&#x000a0;of cancer, diabetes, and heart disease.<xref ref-type="bibr" rid="article-19536.r3">[3]</xref><xref ref-type="bibr" rid="article-19536.r4">[4]</xref></p>
        <p>Managing a patient's chronic pain can significantly impact their quality of life.&#x000a0;Chronic pain, defined as any pain&#x000a0;persisting&#x000a0;beyond&#x000a0;3&#x000a0;months, originates from various sources. Effective pain management often involves a combination of pharmacological treatments and nonpharmacological interventions.&#x000a0;Research results indicate that multimodal combination therapy&#x000a0;yields a more significant reduction in pain than relying solely on single treatments. Escalating&#x000a0;pharmacological therapy&#x000a0;is typically&#x000a0;approached&#x000a0;in a stepwise manner.&#x000a0;Comorbid depression and anxiety&#x000a0;frequently accompany&#x000a0;chronic pain yet often go&#x000a0;undiagnosed&#x000a0;and untreated.&#x000a0;Additionally, individuals&#x000a0;with chronic pain&#x000a0;face an elevated risk of suicide. The pervasive nature of chronic pain can&#x000a0;detrimentally affect every&#x000a0;aspect of a patient's life, potentially resulting in long-term disability and adverse outcomes. Consequently, diagnosing and appropriately managing&#x000a0;chronic pain&#x000a0;is&#x000a0;a critical skill for&#x000a0;healthcare professionals&#x000a0;to cultivate.</p>
      </sec>
      <sec id="article-19536.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Most patients with chronic pain&#x000a0;report experiencing&#x000a0;multiple&#x000a0;types of pain simultaneously.<xref ref-type="bibr" rid="article-19536.r5">[5]</xref>&#x000a0;For instance, an individual with chronic back pain&#x000a0;might also contend with&#x000a0;fibromyalgia.&#x000a0;Moreover,&#x000a0;a considerable proportion of patients with chronic pain also suffer from major depressive and generalized anxiety disorder, with over 67%&#x000a0;experiencing a comorbid psychiatric disorder.<xref ref-type="bibr" rid="article-19536.r6">[6]</xref><xref ref-type="bibr" rid="article-19536.r7">[7]</xref></p>
        <p>Pain manifests in various categories and types, encompassing neuropathic, nociceptive, musculoskeletal, inflammatory, psychogenic, and mechanical forms. The following are some examples of each category:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Neuropathic pain:</bold>&#x000a0;Divided into&#x000a0;2&#x000a0;groups
<list list-type="bullet"><list-item><p>Peripheral neuropathic pain: Postherpetic neuralgia&#x000a0;and diabetic neuropathy</p></list-item><list-item><p>Central neuropathic pain: Cerebral vascular accident sequella</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Nociceptive pain:&#x000a0;</bold>
<list list-type="bullet"><list-item><p>Pain due to actual tissue injuries such as burns, contusions, sprains as well as surgical pain</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Musculoskeletal pain</bold>
<list list-type="bullet"><list-item><p>Back pain, including radicular pain, to the appropriate dermatome</p></list-item><list-item><p>Myofascial pain</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Inflammatory pain</bold>
<list list-type="bullet"><list-item><p>Autoimmune disorders (rheumatoid arthritis, fibromyalgia, and gout)</p></list-item><list-item><p>Infection and cancer pain&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Psychogenic pain</bold>
<list list-type="bullet"><list-item><p>Pain caused by psychological factors, such as headaches or abdominal pain caused by emotional, psychological, or behavioral factors</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Mechanical pain&#x000a0;</bold>
<list list-type="bullet"><list-item><p>Expanding malignancy, benign tumors, advanced ascites, fractures, and retained hardware pain</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19536.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Over 100 million&#x000a0;individuals in the US meet the criteria for chronic pain syndrome, with more than 20 million enduring severe, incapacitating chronic pain.<xref ref-type="bibr" rid="article-19536.r1">[1]</xref>&#x000a0;Among patients with chronic pain, chronic regional pain affects 11.1%, chronic back pain accounts for 10.1%, leg and foot pain affects 7.1%, arm and hand pain affects 4.1%, and headache affects 3.5%.&#x000a0;Additionally,&#x000a0;3.6% of patients with chronic pain experience widespread pain.<xref ref-type="bibr" rid="article-19536.r6">[6]</xref>&#x000a0;</p>
        <p>Older patients receive up to 25% fewer pain medications than the&#x000a0;general population.<xref ref-type="bibr" rid="article-19536.r8">[8]</xref>&#x000a0;Chronic pain is&#x000a0;also associated with&#x000a0;metabolic alterations and cognitive disorders among affected individuals.<xref ref-type="bibr" rid="article-19536.r8">[8]</xref><xref ref-type="bibr" rid="article-19536.r9">[9]</xref>&#x000a0;Studies indicate that&#x000a0;the lifetime prevalence of suicide attempts among patients with chronic pain ranges from&#x000a0;5%&#x000a0;to 14%, with approximately 20% experiencing suicidal ideation.<xref ref-type="bibr" rid="article-19536.r10">[10]</xref>&#x000a0;Among patients with chronic pain who died by&#x000a0;suicide, 53.6%&#x000a0;succumbed to firearm-related injuries, while 16.2% died from an opioid overdose.<xref ref-type="bibr" rid="article-19536.r11">[11]</xref><xref ref-type="bibr" rid="article-19536.r12">[12]</xref><xref ref-type="bibr" rid="article-19536.r13">[13]</xref></p>
      </sec>
      <sec id="article-19536.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Due to the diverse&#x000a0;pathology underlying the cause of pain, no&#x000a0;single physiological finding can&#x000a0;encompass&#x000a0;all the various mechanisms&#x000a0;that produce symptoms. However, it&#x000a0;is&#x000a0;understood&#x000a0;that regardless of the type of pain, the resulting impact is likely similar.<xref ref-type="bibr" rid="article-19536.r14">[14]</xref>&#x000a0;Moreover, the complexity of pain perception and its multifaceted nature shows the importance of a comprehensive approach to pain management.</p>
      </sec>
      <sec id="article-19536.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A thorough medical history is an initial step in diagnosing, differentiating, and evaluating patients with chronic pain. The history should include crucial&#x000a0;details such as the onset date, pain description (eg, burning, throbbing, radicular, superficial, or deep), potential injury mechanisms, pain location, and severity. Additionally, identifying factors that alleviate or exacerbate the pain is essential. Understanding&#x000a0;whether the pain is constant or intermittent (breakthrough pain) or a mix of both aids in determining appropriate treatment options.</p>
        <p>A verbal numeric rating scale or a pain intensity scale ranging from 0-10 is standard for assessing pain severity. Furthermore, it is essential to determine associated symptoms like muscle spasms, skin temperature changes, restricted range of motion, morning stiffness, weakness, muscle strength alterations, sensation changes, and skin, hair, or nail abnormalities.<xref ref-type="bibr" rid="article-19536.r15">[15]</xref></p>
        <p>In addition to assessing the patient's symptoms, it is helpful to explore how chronic pain impacts their day-to-day functioning and quality of life.&#x000a0;This&#x000a0;entails discussing the effect of pain on activities of daily living and overall functionality. Understanding how pain influences relationships, hobbies, and emotional well-being is&#x000a0;vital. Questions about depression, sleep quality, exercise tolerance, work productivity, and the ability to perform basic tasks like toileting, dressing, bathing, walking, or eating without limitations are pertinent to a comprehensive understanding of the patient's condition.</p>
        <p>Following the&#x000a0;comprehensive history, the physical examination should include detailed&#x000a0;assessments of strength, range of motion, and flexibility. The physical examination must corroborate&#x000a0;the details reported in the history and support the patient's pain complaints. Auscultation of the lungs and heart and palpation of the abdomen allow the clinician to observe the patient's movements as they transition onto and off the examination table.<xref ref-type="bibr" rid="article-19536.r16">[16]</xref>&#x000a0;Observation of the patient is&#x000a0;crucial for confirming the reported complaints---allowing the examiner to differentiate&#x000a0;between the patient's perception of pain and any fear or anticipation of pain that can&#x000a0;significantly influence the&#x000a0;treatment plan.<xref ref-type="bibr" rid="article-19536.r16">[16]</xref></p>
        <p>Additionally, a&#x000a0;thorough neurological examination should&#x000a0;be conducted&#x000a0;during the physical assessment. There is benefit in closely examining the area of pain, paying attention to any skin changes, temperature variations between extremities, trophic changes resulting from chronic exposure to heat or cold compresses, and any excoriations from chronic picking. Furthermore, observing for hair loss on the scalp and extremities can provide valuable insights into the patient's condition.<xref ref-type="bibr" rid="article-19536.r17">[17]</xref></p>
        <p>Older adults&#x000a0;constitute&#x000a0;a specific&#x000a0;demographic frequently affected by chronic pain, yet&#x000a0;self-reporting of pain can be&#x000a0;challenging in this population. Accurate self-reporting is crucial for identifying and effectively treating pain; however, difficulties in describing and communicating pain often lead to undertreatment.&#x000a0;Moreover, older patients may&#x000a0;express their pain differently than the&#x000a0;general&#x000a0;population, complicating the diagnosis.<xref ref-type="bibr" rid="article-19536.r8">[8]</xref><xref ref-type="bibr" rid="article-19536.r18">[18]</xref>&#x000a0;Rather than explicitly labeling it pain, an older individual might only describe soreness or discomfort.<xref ref-type="bibr" rid="article-19536.r19">[19]</xref><xref ref-type="bibr" rid="article-19536.r20">[20]</xref><xref ref-type="bibr" rid="article-19536.r21">[21]</xref></p>
      </sec>
      <sec id="article-19536.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The Brief Pain Inventory (BPI)&#x000a0;is a valuable tool for evaluating patients' perceptions of&#x000a0;pain and its impact on their daily lives.<xref ref-type="bibr" rid="article-19536.r22">[22]</xref><xref ref-type="bibr" rid="article-19536.r23">[23]</xref>&#x000a0;Additionally, the McGill Pain Questionnaire (SF-MPQ-2) includes a pain location drawing, a questionnaire regarding previous pain medication use, and experiences with pain history.<xref ref-type="bibr" rid="article-19536.r24">[24]</xref>&#x000a0;Neuropathic pain is assessable using the Neuropathic Pain Scale to&#x000a0;monitor responses to therapy.</p>
        <p>Standard blood work and imaging&#x000a0;are not&#x000a0;recommended&#x000a0;for routine evaluation of chronic pain. However, clinicians may order&#x000a0;these tests&#x000a0;when specific underlying causes are suspected. Laboratory studies can&#x000a0;be requested&#x000a0;on a case-by-case basis, including baseline studies to&#x000a0;evaluate&#x000a0;liver function when&#x000a0;certain medications with potential hepatic side effects&#x000a0;are prescribed.</p>
        <p>Psychiatric disorders can&#x000a0;exacerbate pain signaling,&#x000a0;intensifying pain symptoms.<xref ref-type="bibr" rid="article-19536.r25">[25]</xref>&#x000a0;Furthermore, comorbid psychiatric conditions, such as major depressive disorder, can significantly delay the diagnosis of pain disorders.<xref ref-type="bibr" rid="article-19536.r7">[7]</xref><xref ref-type="bibr" rid="article-19536.r26">[26]</xref>&#x000a0;Major depressive disorder and generalized anxiety disorders are the most&#x000a0;prevalent&#x000a0;comorbidities&#x000a0;associated&#x000a0;with chronic pain.</p>
        <p>Patients with underlying pain and comorbid psychiatric disorders receive approximately twice as many opioid prescriptions annually compared to&#x000a0;those without such comorbidity.<xref ref-type="bibr" rid="article-19536.r19">[19]</xref>&#x000a0;For instance, individuals with depression commonly experience fatigue, sleep disturbances,&#x000a0;decreased appetite, and&#x000a0;reduced activity levels, all of which can exacerbate pain symptoms over time.&#x000a0;Patients with chronic pain&#x000a0;face an elevated&#x000a0;risk&#x000a0;of suicide and suicidal ideation.<xref ref-type="bibr" rid="article-19536.r10">[10]</xref><xref ref-type="bibr" rid="article-19536.r11">[11]</xref></p>
        <p>Screening for depression is&#x000a0;advised for patients&#x000a0;experiencing chronic pain. The Minnesota Multiphasic Personality Inventory-II (MMPI-2)&#x000a0;and Beck Depression Scale are the&#x000a0;primary assessment tools utilized for this purpose. Among these, the MMPI-2&#x000a0;is more commonly used&#x000a0;for patients with chronic pain.<xref ref-type="bibr" rid="article-19536.r27">[27]</xref><xref ref-type="bibr" rid="article-19536.r28">[28]</xref><xref ref-type="bibr" rid="article-19536.r29">[29]</xref><xref ref-type="bibr" rid="article-19536.r30">[30]</xref></p>
      </sec>
      <sec id="article-19536.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>When&#x000a0;debilitating pain persists despite therapeutic interventions, referral to a pain management specialist is warranted. The pain may be widespread,&#x000a0;necessitating multimodal treatment approaches or&#x000a0;adjustments in&#x000a0;medication dosages&#x000a0;to achieve adequate pain control. In some cases, invasive procedures designed to control refractory pain may be recommended.</p>
        <p>It is essential to address both the pain itself and any comorbid conditions, especially psychiatric disorders,&#x000a0;to develop a comprehensive treatment plan. Research indicates that addressing both pain and psychiatric disorders leads to more significant reductions in pain severity and associated symptoms.<xref ref-type="bibr" rid="article-19536.r31">[31]</xref><xref ref-type="bibr" rid="article-19536.r32">[32]</xref>&#x000a0;Moreover, chronic pain&#x000a0;can&#x000a0;exacerbate concurrent depression, highlighting the importance of pain management in improving responses to depression.<xref ref-type="bibr" rid="article-19536.r33">[33]</xref><xref ref-type="bibr" rid="article-19536.r34">[34]</xref> Patients have access to various pharmacological, adjunct, nonpharmacological, and interventional treatments tailored to their needs for managing chronic, severe, and refractory pain.</p>
        <p>The&#x000a0;array of pharmacological options for chronic pain management is extensive. Nonopioid analgesics such as nonsteroidal anti-inflammatories (NSAIDs), acetaminophen, and aspirin are commonly used. Additionally, medications such as tramadol, opioids, and antiepileptic drugs like gabapentin or pregabalin can be effective. Furthermore, antidepressants such as tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors (SNRIs), topical analgesics, muscle relaxers, N-methyl-d-aspartate (NMDA) receptor antagonists, and alpha 2 adrenergic agonists are also possible pharmacological therapies for managing chronic pain.<xref ref-type="bibr" rid="article-19536.r32">[32]</xref></p>
        <p>Treatment responses can&#x000a0;vary&#x000a0;among individuals, but typically, a stepwise&#x000a0;approach is adopted to minimize the duration and dosage of opioid analgesics. However, there is no singular approach to pain treatment, underscoring the significance of conducting a comprehensive initial work-up.<xref ref-type="bibr" rid="article-19536.r35">[35]</xref></p>
        <p>Chronic musculoskeletal pain, characterized as nociceptive pain, is typically managed in a stepwise&#x000a0;manner, often&#x000a0;incorporating a&#x000a0;combination of nonopioid analgesics, opioids, and nonpharmacological therapies. Acetaminophen&#x000a0;and NSAIDs serve as first-line therapies due to their efficacy in conditions like osteoarthritis and chronic back pain.<xref ref-type="bibr" rid="article-19536.r36">[36]</xref><xref ref-type="bibr" rid="article-19536.r37">[37]</xref><xref ref-type="bibr" rid="article-19536.r38">[38]</xref><xref ref-type="bibr" rid="article-19536.r39">[39]</xref>&#x000a0;However, NSAIDs are relatively contraindicated for individuals with a history of heart disease, myocardial infarction, renal disease, or&#x000a0;those on anticoagulation or with a history of ulcers.<xref ref-type="bibr" rid="article-19536.r40">[40]</xref><xref ref-type="bibr" rid="article-19536.r41">[41]</xref>&#x000a0;There is limited evidence to suggest one NSAID is superior to another; therefore, trying different agents is recommended before considering opioid analgesics.<xref ref-type="bibr" rid="article-19536.r42">[42]</xref> If adequate pain relief&#x000a0;is not achieved with acetaminophen or NSAIDs, opioid analgesics may be considered.&#x000a0;</p>
        <p>Opioids are considered a second-line option for pain management; however, they may be warranted&#x000a0;in cases of severe persistent pain or neuropathic pain secondary to&#x000a0;malignancy.<xref ref-type="bibr" rid="article-19536.r43">[43]</xref>&#x000a0;The evidence regarding the use of opioids in neuropathic pain is mixed, but they are often utilized for short-term and intermediate pain relief in this context.<xref ref-type="bibr" rid="article-19536.r44">[44]</xref><xref ref-type="bibr" rid="article-19536.r45">[45]</xref>&#x000a0;When initiating opioid therapy for chronic musculoskeletal pain, extreme caution is advised due to the significant side effects associated with opioids, including opioid-induced hyperalgesia, constipation, dependence, and sedation.<xref ref-type="bibr" rid="article-19536.r46">[46]</xref>&#x000a0;Additionally, for chronic musculoskeletal pain, opioids&#x000a0;are not found to be superior to nonopioid analgesics.<xref ref-type="bibr" rid="article-19536.r47">[47]</xref><xref ref-type="bibr" rid="article-19536.r48">[48]</xref></p>
        <p>The administration&#x000a0;of opioid analgesics is&#x000a0;recommended when alternative pain medications have&#x000a0;proven&#x000a0;ineffective or contraindicated and when&#x000a0;pain&#x000a0;significantly&#x000a0;impacts the patient's quality of life,&#x000a0;with the potential benefits outweighing the short and long-term effects of opioid therapy. However, patients must make an informed&#x000a0;decision before&#x000a0;initiating opioid treatment, following a thorough&#x000a0;discussion&#x000a0;of the associated risks, benefits, and available alternatives.<xref ref-type="bibr" rid="article-19536.r47">[47]</xref><xref ref-type="bibr" rid="article-19536.r49">[49]</xref><xref ref-type="bibr" rid="article-19536.r50">[50]</xref>&#x000a0;</p>
        <p>Notably, patients taking opioids at doses exceeding 100 morphine&#x000a0;milligram equivalents per day are at significantly increased risk of side effects, with respiratory compromise becoming more prevalent as dosages escalate. Therefore, patients with chronic pain&#x000a0;may benefit from a structured therapy program aimed at tapering them&#x000a0;off high-opioid&#x000a0;regimens to safer levels.<xref ref-type="bibr" rid="article-19536.r51">[51]</xref><xref ref-type="bibr" rid="article-19536.r52">[52]</xref>&#x000a0;Long-acting opioids should be&#x000a0;reserved&#x000a0;for cases of disabling pain that severely impairs quality of life, with&#x000a0;short-acting opioids&#x000a0;preferred otherwise.<xref ref-type="bibr" rid="article-19536.r53">[53]</xref><xref ref-type="bibr" rid="article-19536.r54">[54]</xref></p>
        <p>There is an estimated 78% risk of&#x000a0;experiencing adverse reactions to opioids,&#x000a0;including constipation or nausea,&#x000a0;with&#x000a0;a 7.5% risk of severe adverse reactions, ranging from immunosuppression to respiratory depression.<xref ref-type="bibr" rid="article-19536.r55">[55]</xref>&#x000a0;For patients with chronic pain who meet the criteria for opioid use disorder, buprenorphine should be considered as an option for managing their pain. Buprenorphine is a&#x000a0;preferable&#x000a0;alternative, especially for individuals with very high daily morphine equivalents who have&#x000a0;not achieved sufficient analgesia with other treatments.<xref ref-type="bibr" rid="article-19536.r56">[56]</xref><xref ref-type="bibr" rid="article-19536.r57">[57]</xref><xref ref-type="bibr" rid="article-19536.r58">[58]</xref></p>
        <p>Different types of pain warrant&#x000a0;distinct treatment approaches. For example, chronic musculoskeletal back pain would be&#x000a0;managed differently from severe diabetic neuropathy. Neuropathic pain often requires a combination of multiple pharmacological therapies, as less than 50% of patients achieve adequate pain relief with a single agent.<xref ref-type="bibr" rid="article-19536.r59">[59]</xref>&#x000a0;Adjunctive topical therapies, such as lidocaine or capsaicin cream, can also be beneficial in managing neuropathic pain.<xref ref-type="bibr" rid="article-19536.r60">[60]</xref><xref ref-type="bibr" rid="article-19536.r61">[61]</xref><xref ref-type="bibr" rid="article-19536.r62">[62]</xref></p>
        <p>The initial pharmacological approach to treating neuropathic pain often&#x000a0;involves gabapentin or pregabalin, both of which are calcium channel alpha 2-delta ligands. The medications are indicated for conditions like postherpetic neuralgia, diabetic neuropathy, and mixed neuropathy.<xref ref-type="bibr" rid="article-19536.r63">[63]</xref>&#x000a0;While there is limited evidence supporting the use of other antiepileptic medications to treat chronic pain, where many of these, such as lamotrigine, have a more significant side effect profile. The exception is carbamazepine in the treatment of trigeminal neuralgia and other&#x000a0;forms of chronic neuropathic pain.<xref ref-type="bibr" rid="article-19536.r64">[64]</xref><xref ref-type="bibr" rid="article-19536.r65">[65]</xref></p>
        <p>Alternatively, antidepressants such as dual reuptake inhibitors of serotonin and norepinephrine (SNRI) or tricyclic antidepressants (TCA) represent another treatment option. Antidepressants are beneficial in managing neuropathic pain, central pain syndromes, and chronic musculoskeletal pain.&#x000a0;In the case of neuropathic pain, antidepressants have demonstrated a 50% reduction in pain intensity. This substantial reduction is noteworthy, especially considering that the average pain reduction achieved by various pain treatments is around 30%.<xref ref-type="bibr" rid="article-19536.r66">[66]</xref><xref ref-type="bibr" rid="article-19536.r67">[67]</xref><xref ref-type="bibr" rid="article-19536.r68">[68]</xref></p>
        <p>The SNRI duloxetine is&#x000a0;effective&#x000a0;in treating chronic pain, osteoarthritis, and fibromyalgia.<xref ref-type="bibr" rid="article-19536.r69">[69]</xref>&#x000a0;Furthermore, duloxetine demonstrates comparable efficacy in treating comorbid depression when compared to other antidepressants.<xref ref-type="bibr" rid="article-19536.r66">[66]</xref><xref ref-type="bibr" rid="article-19536.r70">[70]</xref>&#x000a0;Venlafaxine is&#x000a0;another effective&#x000a0;option for treating neuropathic pain.<xref ref-type="bibr" rid="article-19536.r71">[71]</xref>&#x000a0;TCAs, such as nortriptyline, can also be utilized for pain management. However, it is important to note that TCAs may require&#x000a0; 6-8 weeks to achieve their desired therapeutic effect.<xref ref-type="bibr" rid="article-19536.r43">[43]</xref></p>
        <p>Adjunctive topical agents, such as topical lidocaine, are beneficial for managing neuropathic pain and allodynia, as&#x000a0;observed in postherpetic neuralgia.<xref ref-type="bibr" rid="article-19536.r72">[72]</xref><xref ref-type="bibr" rid="article-19536.r73">[73]</xref>&#x000a0;While topical NSAIDs have&#x000a0;demonstrated efficacy in improving&#x000a0;acute musculoskeletal pain, such as strains,&#x000a0;their effectiveness in chronic pain is limited. However, they are more effective than controls in treating pain associated with knee osteoarthritis.<xref ref-type="bibr" rid="article-19536.r74">[74]</xref><xref ref-type="bibr" rid="article-19536.r75">[75]</xref>&#x000a0;</p>
        <p>Additionally, topical capsaicin cream is an option for chronic neuropathic or musculoskeletal pain that is unresponsive to other treatments.<xref ref-type="bibr" rid="article-19536.r76">[76]</xref>&#x000a0;Botulinum toxin has also demonstrated effectiveness in the treatment of postherpetic neuralgia.<xref ref-type="bibr" rid="article-19536.r77">[77]</xref>&#x000a0;Cannabis use is an area of interest in pain research, with some evidence suggesting that medical marijuana can effectively treat neuropathic pain,&#x000a0;although&#x000a0;evidence for&#x000a0;treating other types of chronic pain remains limited.<xref ref-type="bibr" rid="article-19536.r78">[78]</xref></p>
        <p>The&#x000a0;array of nonpharmacological therapies for chronic pain is extensive. These options include heat and cold therapy, cognitive behavioral therapy, relaxation therapy, biofeedback, group counseling, ultrasound stimulation, acupuncture, aerobic exercise, chiropractic, physical therapy, osteopathic manipulative medicine, occupational therapy, and transcutaneous electrical nerve stimulation (TENS) units. In addition to these therapies, interventional techniques are crucial in chronic pain treatment. These techniques include spinal cord stimulation, epidural steroid injections, radiofrequency nerve ablations, botulinum toxin injections, nerve blocks, trigger point injections, and intrathecal pain pumps.</p>
        <p>The efficacy of TENS units has shown variability, and their role in chronic pain management remains inconclusive.<xref ref-type="bibr" rid="article-19536.r79">[79]</xref>&#x000a0;Deep brain stimulation is&#x000a0;reserved for post-stroke and facial pain, as well as severe, intractable pain&#x000a0;refractory to&#x000a0;other treatments.<xref ref-type="bibr" rid="article-19536.r80">[80]</xref>&#x000a0;While evidence for interventional approaches to pain management is limited, implantable intrathecal delivery systems can be considered for patients with refractory pain who have exhausted all other options.</p>
        <p>Spinal cord stimulators represent a viable option for patients with chronic pain who have not responded to conservative treatments. While they are most frequently implanted following failed back surgery, they can be considered for various other causes of chronic pain, including complex regional pain syndrome, painful peripheral vascular disease, intractable angina, painful diabetic neuropathy,&#x000a0;and visceral abdominal and perineal pain.<xref ref-type="bibr" rid="article-19536.r81">[81]</xref><xref ref-type="bibr" rid="article-19536.r82">[82]</xref><xref ref-type="bibr" rid="article-19536.r83">[83]</xref><xref ref-type="bibr" rid="article-19536.r84">[84]</xref><xref ref-type="bibr" rid="article-19536.r85">[85]</xref>&#x000a0;Research indicates&#x000a0;that spinal cord stimulators&#x000a0;can lead to a significant&#x000a0;50% reduction in pain compared to continued medical therapy.<xref ref-type="bibr" rid="article-19536.r86">[86]</xref><xref ref-type="bibr" rid="article-19536.r87">[87]</xref><xref ref-type="bibr" rid="article-19536.r88">[88]</xref></p>
      </sec>
      <sec id="article-19536.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Pain is a symptom, not a diagnosis. Therefore, developing a differential diagnosis for a patient's chronic pain involves assessing their underlying etiologies. Determining&#x000a0;the underlying injury or disease process responsible for the pain is essential because effective treatment hinges on understanding the etiology.&#x000a0;For instance, distinguishing between&#x000a0;peripheral&#x000a0;and central neuropathic pain is necessary as it dictates the most effective treatment modality.</p>
        <p>Similarly,&#x000a0;when a patient&#x000a0;presents&#x000a0;with severe knee pain, it is essential to&#x000a0;differentiate between conditions like&#x000a0;severe osteoarthritis&#x000a0;and&#x000a0;rheumatoid arthritis. This determination influences whether treatments such as injections or knee replacement would be beneficial. Conversely, if the knee pain were due to conditions like rheumatoid arthritis, infection, gout, pseudogout, or meniscal injury, different treatments could be&#x000a0;more efficacious.</p>
        <p>The differential diagnosis for generalized chronic pain&#x000a0;encompasses&#x000a0;various conditions, including patients who develop&#x000a0;allodynia from chronic opioid use, those suffering from major depressive disorder,&#x000a0;and other psychiatric disorders like bipolar disorder and schizophrenia. Furthermore, autoimmune diseases such as lupus or psoriatic arthritis, fibromyalgia, and central pain syndromes should be considered in&#x000a0;cases involving widespread, generalized chronic pain.</p>
        <p>The&#x000a0;4 main categories of pain&#x02014;neuropathic, musculoskeletal, mechanical, and inflammatory&#x02014;should guide the diagnostic process. Persistent and undertreated painful conditions can lead to chronic pain, which often becomes a symptom of one or multiple diagnoses and can eventually become a diagnosis itself as it persists and alters the body's neurochemistry. Treating acute and subacute pain promptly is crucial in preventing the development of chronic pain syndromes.&#x000a0;</p>
      </sec>
      <sec id="article-19536.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Current chronic pain treatments can result in an estimated 30% decrease in a patient's pain scores.<xref ref-type="bibr" rid="article-19536.r35">[35]</xref> A thirty percent reduction in a patient's pain can significantly improve patients' function and quality of life.<xref ref-type="bibr" rid="article-19536.r89">[89]</xref> However, the long-term prognosis for patients with chronic pain demonstrates reduced function and quality of life. Improved outcomes are possible in patients with chronic pain improves with the treatment of comorbid psychiatric illness.&#x000a0;Chronic pain increases patient morbidity and mortality, as well as increases rates of chronic disease and obesity.&#x000a0;Patients with chronic pain are also at a significantly increased risk for suicide compared to the regular population.</p>
        <p>Spinal cord stimulation results in inadequate pain relief in about 50% of patients. Tolerance can also occur in up to 20 to 40 percent of patients. The effectiveness of the spinal cord stimulation decreases over time.<xref ref-type="bibr" rid="article-19536.r90">[90]</xref> Similarly, patients who develop chronic pain and are dependent on opioids often build tolerance over time. As the amount of morphine milligram equivalents increases, the patient's morbidity and mortality also increase.</p>
        <p>Ultimately, prevention is critical in the treatment of chronic pain. If acute and subacute pain receives appropriate treatment and chronic pain can be avoided, the patient will have limited impacts on their quality of life.&#x000a0;</p>
      </sec>
      <sec id="article-19536.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Chronic pain significantly decreases quality of life and productivity and can lead to lost wages.&#x000a0;It worsens&#x000a0;chronic diseases and contributes to psychiatric disorders such as depression, anxiety, and substance abuse disorders. Patients with chronic pain&#x000a0;face a significantly increased risk of suicide and suicidal ideation.</p>
        <p>Many medications commonly used to treat chronic pain carry potential risks, side effects, and possible complications.&#x000a0;Acetaminophen is a standard pharmacological therapy for patients with chronic pain, taken either as a single agent or in combination with an opioid. However,&#x000a0;hepatotoxicity&#x000a0;can occur, especially with doses exceeding&#x000a0;4 grams per day, making it the most common cause of acute liver failure in the US.<xref ref-type="bibr" rid="article-19536.r91">[91]</xref><xref ref-type="bibr" rid="article-19536.r92">[92]</xref>&#x000a0;Furthermore, hepatotoxicity can occur at therapeutic doses for patients&#x000a0;diagnosed with chronic liver disease.<xref ref-type="bibr" rid="article-19536.r93">[93]</xref></p>
        <p>Frequently used adjunct medications such as gabapentin or pregabalin can cause sedation, swelling, mood changes, confusion, and respiratory depression in older patients who require additional analgesics.<xref ref-type="bibr" rid="article-19536.r94">[94]</xref>&#x000a0;These agents require caution in&#x000a0;older patients with painful diabetic neuropathy. Moreover, combining gabapentin or pregabalin with opioid analgesics has&#x000a0;been shown to increase the rate of patient mortality.<xref ref-type="bibr" rid="article-19536.r95">[95]</xref></p>
        <p>Duloxetine can cause mood changes, headaches, nausea, and other possible side effects and should be avoided in patients with a history of kidney or liver disease. Patients with these conditions should be closely monitored if duloxetine is prescribed.</p>
        <p>Feared complications of opioid therapy include addiction, overdose resulting in respiratory compromise, and occasionally, death. However, opioid-induced hyperalgesia is also a significant concern, where patients become more sensitive to painful stimuli while on chronic opioids.<xref ref-type="bibr" rid="article-19536.r96">[96]</xref>&#x000a0;The long-term risks and side effects of opioids include constipation, tolerance, dependence, nausea, dyspepsia, arrhythmia (methadone treatment QT prolongation), and opioid-induced endocrine dysfunction, which can result in amenorrhea, impotence, gynecomastia, and decreased energy and libido. Additionally, there appears to be a dose-dependent risk of opioid overdose with increasing daily milligram morphine equivalents.</p>
        <p>Complication rates for spinal cord stimulators are high, ranging from&#x000a0;5% up to 40%.<xref ref-type="bibr" rid="article-19536.r97">[97]</xref><xref ref-type="bibr" rid="article-19536.r98">[98]</xref>&#x000a0;Most commonly, lead migration occurs, causing inadequate pain relief and requiring revision and anchoring.<xref ref-type="bibr" rid="article-19536.r99">[99]</xref><xref ref-type="bibr" rid="article-19536.r100">[100]</xref>&#x000a0;Lead movement often occurs in the cervical region of the spinal cord, given an increased range of motion of the cervical vertebra.<xref ref-type="bibr" rid="article-19536.r101">[101]</xref><xref ref-type="bibr" rid="article-19536.r102">[102]</xref>&#x000a0;Spinal cord stimulator lead&#x000a0;fracture can occur in up to 9% of placements.<xref ref-type="bibr" rid="article-19536.r103">[103]</xref><xref ref-type="bibr" rid="article-19536.r104">[104]</xref>&#x000a0;Seromas are also very common&#x000a0;and may require surgical incision and drainage.<xref ref-type="bibr" rid="article-19536.r97">[97]</xref><xref ref-type="bibr" rid="article-19536.r105">[105]</xref>&#x000a0;The risk of infection following a spinal cord stimulator placement is between 2.5% and 12%.<xref ref-type="bibr" rid="article-19536.r106">[106]</xref><xref ref-type="bibr" rid="article-19536.r107">[107]</xref>&#x000a0;Lastly, direct spinal cord trauma could occur. The most significant infectious complication would be a spinal cord abscess. Dural puncture is rare but can cause a post-dural headache in up to 70% of patients.<xref ref-type="bibr" rid="article-19536.r105">[105]</xref><xref ref-type="bibr" rid="article-19536.r108">[108]</xref><xref ref-type="bibr" rid="article-19536.r109">[109]</xref>&#x000a0;The most critical adverse event in spinal cord stimulator placement would be a spinal epidural hematoma, which requires immediate neurosurgical decompression. The incidence of a spinal epidural hematoma is 0.71%.<xref ref-type="bibr" rid="article-19536.r110">[110]</xref></p>
      </sec>
      <sec id="article-19536.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Chronic pain management is most effective when handled by an interprofessional team, which includes a primary care physician and a pain management specialist. A multimodal treatment approach is optimal for achieving better pain control and outcomes while minimizing the need for high-risk treatments such as opioids.</p>
        <p>Medication dosages should be gradually increased stepwise and titrated according to the patient's pain level. Patients on chronic opioids should&#x000a0;be offered&#x000a0;medications for opioid addiction if there are concerns about dependence or misuse. Clinicians can offer interventional procedures to patients with chronic pain who are unresponsive to medications or those who wish to reduce or discontinue chronic opioid treatment.</p>
        <p>Management of comorbid depression and anxiety is crucial for reducing chronic pain. The&#x000a0;older population may describe pain differently than the average population. Following spinal cord stimulator implantation, patients should have periodic visits with their pain provider to adjust the stimulator's settings for maximum effectiveness. Patients with chronic pain should&#x000a0;be closely monitored&#x000a0;for severe depression and suicidal ideation. Regular assessment and intervention for mental health issues are essential in ensuring the overall well-being of chronic pain patients with chronic pain.</p>
      </sec>
      <sec id="article-19536.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about chronic pain management include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Multimodal approach: Combine pharmacological and nonpharmacological therapies for better pain control.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Interprofessional team: Primary care physicians and pain management specialists work together.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Medication management:
<list list-type="bullet"><list-item><p>Start with nonopioid analgesics like acetaminophen or NSAIDs.</p></list-item><list-item><p>Gradually increase dosages stepwise according to pain.</p></list-item><list-item><p>Be cautious of side effects of adjunct medications like gabapentin or pregabalin.</p></list-item><list-item><p>Offer opioid addiction medications if misuse is a concern.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Interventional procedures: Consider for refractory pain or opioid reduction.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Psychological factors: Manage comorbid depression and anxiety.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Older&#x000a0;patients: Note different pain expressions and special considerations.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Monitoring: Regularly assess for severe depression or suicidal ideation.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Safety concerns with opioids:
<list list-type="bullet"><list-item><p>Know risks like addiction, overdose, and hyperalgesia.</p></list-item><list-item><p>Understand long-term effects like constipation, tolerance, and dependence.</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19536.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Chronic pain is a complex condition with significant implications for patient's quality of life, requiring a comprehensive and interprofessional approach to management. To ensure patient-centered care, favorable outcomes, patient safety, and effective team performance, healthcare professionals across various disciplines must possess specific skills, adhere to ethical principles, understand their responsibilities, communicate effectively, and coordinate care efficiently.</p>
        <p>Healthcare professionals in chronic pain management must possess various skills, including advanced assessment techniques, knowledge of evidence-based treatments, and proficiency in administering multiple therapies. Physicians, advanced practitioners, nurses, pharmacists, and other healthcare providers should continually update their skills through training and education to deliver the best possible care to patients with chronic pain.</p>
        <p>A strategic approach to chronic pain management involves early evaluation, conservative treatment when symptoms are mild or moderate, and escalation of therapy as needed. A pharmacist should evaluate pharmacological management regularly to prevent adverse drug interactions. The interprofessional team should develop a cohesive plan that addresses the patient's physical, psychological, and social needs.</p>
        <p>Each member of the interprofessional team has specific responsibilities in chronic pain management. Physicians and advanced practitioners are responsible for accurate diagnosis and treatment planning, while nurses monitor patient progress and compliance with the treatment plan. Pharmacists ensure medication safety and reconciliation; other healthcare professionals contribute their expertise as needed.</p>
        <p>Effective communication among team members is crucial for providing seamless care to patients with chronic pain. Regular meetings, case conferences, and shared electronic health records facilitate communication and collaboration, ensuring alignment of treatment goals and timely interventions.</p>
        <p>Coordinating care across different settings and disciplines is essential to address the multifaceted nature of chronic pain. Patients should have regular follow-up appointments with their primary care provider and specialists as needed. Nursing is crucial in monitoring patient progress, identifying adverse effects, and communicating concerns to the treating physicians.</p>
        <p>Additionally, nurses can support patients with chronic pain by providing education on pain management techniques, facilitating access to resources, and advocating for their needs within the healthcare system. Pharmacists can conduct medication therapy management to optimize drug therapy and provide patient education on medication use and side effects.</p>
        <p>In summary, by enhancing skills, adopting strategic approaches, upholding ethical principles, fulfilling responsibilities, promoting interprofessional communication, and coordinating care effectively, healthcare professionals can enhance patient-centered care, improve outcomes, ensure patient safety, and optimize team performance in chronic pain management.</p>
      </sec>
      <sec id="article-19536.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19536&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19536">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/chronic-pain-longterm-pain/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19536">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19536/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19536">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19536.s16">
        <title>References</title>
        <ref id="article-19536.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nahin</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Estimates of pain prevalence and severity in adults: United States, 2012.</article-title>
            <source>J Pain</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>16</volume>
            <issue>8</issue>
            <fpage>769</fpage>
            <page-range>769-80</page-range>
            <pub-id pub-id-type="pmid">26028573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alford</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Krebs</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Nicolaidis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bair</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Liebschutz</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Update in pain medicine.</article-title>
            <source>J Gen Intern Med</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>11</issue>
            <fpage>1222</fpage>
            <page-range>1222-6</page-range>
            <pub-id pub-id-type="pmid">20632120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pizzo</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Alleviating suffering 101--pain relief in the United States.</article-title>
            <source>N Engl J Med</source>
            <year>2012</year>
            <month>Jan</month>
            <day>19</day>
            <volume>366</volume>
            <issue>3</issue>
            <fpage>197</fpage>
            <page-range>197-9</page-range>
            <pub-id pub-id-type="pmid">22256802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bulls</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Hamm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wasilewski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Olejniczak</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Liebschutz</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>"To prescribe or not to prescribe, that is the question": Perspectives on opioid prescribing for chronic, cancer-related pain from clinicians who treat pain in survivorship.</article-title>
            <source>Cancer</source>
            <year>2024</year>
            <month>Sep</month>
            <day>01</day>
            <volume>130</volume>
            <issue>17</issue>
            <fpage>3034</fpage>
            <page-range>3034-3042</page-range>
            <pub-id pub-id-type="pmid">38567685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hardt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jacobsen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nickel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Buchwald</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of chronic pain in a representative sample in the United States.</article-title>
            <source>Pain Med</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>7</issue>
            <fpage>803</fpage>
            <page-range>803-12</page-range>
            <pub-id pub-id-type="pmid">18346058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Annag&#x000fc;r</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Uguz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Apiliogullari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kara</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gunduz</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Psychiatric disorders and association with quality of sleep and quality of life in patients with chronic pain: a SCID-based study.</article-title>
            <source>Pain Med</source>
            <year>2014</year>
            <month>May</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>772</fpage>
            <page-range>772-81</page-range>
            <pub-id pub-id-type="pmid">24612225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roy</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lally</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Akerman</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Fratantonio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Flanders</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Wenten</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder.</article-title>
            <source>BMC Psychiatry</source>
            <year>2024</year>
            <month>Apr</month>
            <day>02</day>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>244</fpage>
            <pub-id pub-id-type="pmid">38566055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldt</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Ryden</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Miles</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment of pain in cognitively impaired compared with cognitively intact older patients with hip-fracture.</article-title>
            <source>J Am Geriatr Soc</source>
            <year>1998</year>
            <month>Sep</month>
            <volume>46</volume>
            <issue>9</issue>
            <fpage>1079</fpage>
            <page-range>1079-85</page-range>
            <pub-id pub-id-type="pmid">9736099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moriya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sakatani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kitahara</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Estimation of cognitive impairment in chronic pain patients and characteristics of estimated mild cognitive impairment.</article-title>
            <source>Front Neurol</source>
            <year>2024</year>
            <volume>15</volume>
            <fpage>1344190</fpage>
            <pub-id pub-id-type="pmid">38523612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Crane</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links.</article-title>
            <source>Psychol Med</source>
            <year>2006</year>
            <month>May</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>575</fpage>
            <page-range>575-86</page-range>
            <pub-id pub-id-type="pmid">16420727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petrosky</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Harpaz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bohm</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Helmick</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Betz</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Chronic Pain Among Suicide Decedents, 2003 to 2014: Findings From the National Violent Death Reporting System.</article-title>
            <source>Ann Intern Med</source>
            <year>2018</year>
            <month>Oct</month>
            <day>02</day>
            <volume>169</volume>
            <issue>7</issue>
            <fpage>448</fpage>
            <page-range>448-455</page-range>
            <pub-id pub-id-type="pmid">30208405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balit</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Erlangsen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Docherty</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Turecki</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Orri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Association of chronic pain with suicide attempt and death by suicide: a two-sample Mendelian randomization.</article-title>
            <source>Mol Psychiatry</source>
            <year>2024</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>7</issue>
            <fpage>2043</fpage>
            <page-range>2043-2049</page-range>
            <pub-id pub-id-type="pmid">38366113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Redding</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kalesnikava</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Bergmans</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Redding</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dent</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mezuk</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Medically unexplained pain and suicidal ideation among US adults.</article-title>
            <source>J Affect Disord</source>
            <year>2024</year>
            <month>Apr</month>
            <day>15</day>
            <volume>351</volume>
            <fpage>425</fpage>
            <page-range>425-429</page-range>
            <pub-id pub-id-type="pmid">38272364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howlett</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Stanford</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Berryman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Karran</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Bellan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Coussens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miles</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moseley</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Investigating self-report and neuropsychological assessments of cognitive flexibility in people with and without persistent pain: An online, cross-sectional, observational study.</article-title>
            <source>Br J Pain</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>176</fpage>
            <page-range>176-196</page-range>
            <pub-id pub-id-type="pmid">38545498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burden</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Bissonnette</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Anatchkova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Budhiarso</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Skalicky</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Liberato</surname>
                <given-names>ACS</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thoma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gloede</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kohlmann</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lebwohl</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasis.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2024</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>7</issue>
            <fpage>1383</fpage>
            <page-range>1383-1390</page-range>
            <pub-id pub-id-type="pmid">38334243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Venturin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Battimelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>di Cara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Poser</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The multidisciplinary team in the management of chronic pain and pain-related fear: an evidence-based approach in a clinical case.</article-title>
            <source>Physiother Theory Pract</source>
            <year>2024</year>
            <month>Mar</month>
            <day>29</day>
            <fpage>1</fpage>
            <page-range>1-18</page-range>
            <pub-id pub-id-type="pmid">38551215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karagounis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Oza</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Chronic tongue pain and alopecia.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>e58</fpage>
            <page-range>e58-e60</page-range>
            <pub-id pub-id-type="pmid">34931369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <collab>AGS Panel on Persistent Pain in Older Persons</collab>
            <article-title>The management of persistent pain in older persons.</article-title>
            <source>J Am Geriatr Soc</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>6 Suppl</issue>
            <fpage>S205</fpage>
            <page-range>S205-24</page-range>
            <pub-id pub-id-type="pmid">12067390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Closs</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Briggs</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Patients' verbal descriptions of pain and discomfort following orthopaedic surgery.</article-title>
            <source>Int J Nurs Stud</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>563</fpage>
            <page-range>563-72</page-range>
            <pub-id pub-id-type="pmid">11996877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pickering</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Engelen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stupar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ganry</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Eerdekens</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Is the Capsaicin 179 mg (8% w/w) Cutaneous Patch an Appropriate Treatment Option for Older Patients with Peripheral Neuropathic Pain?</article-title>
            <source>J Pain Res</source>
            <year>2024</year>
            <volume>17</volume>
            <fpage>1327</fpage>
            <page-range>1327-1344</page-range>
            <pub-id pub-id-type="pmid">38560405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hughes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Atee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chivers</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hoti</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Comments on Pu et&#x000a0;al. (2024) 'Associations between facial expressions and observational pain in residents with dementia and chronic pain'.</article-title>
            <source>J Adv Nurs</source>
            <year>2024</year>
            <month>Apr</month>
            <day>01</day>
            <pub-id pub-id-type="pmid">38558457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bann</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Dodd</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Schein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mendoza</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Cleeland</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain.</article-title>
            <source>Clin J Pain</source>
            <year>2004</year>
            <season>Sep-Oct</season>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>309</fpage>
            <page-range>309-18</page-range>
            <pub-id pub-id-type="pmid">15322437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cleeland</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Pain assessment: global use of the Brief Pain Inventory.</article-title>
            <source>Ann Acad Med Singap</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-38</page-range>
            <pub-id pub-id-type="pmid">8080219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dworkin</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Turk</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Revicki</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Harding</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Coyne</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Peirce-Sandner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhagwat</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Everton</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Burke</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Cowan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Farrar</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Hertz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Max</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Rappaport</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Melzack</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2).</article-title>
            <source>Pain</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>144</volume>
            <issue>1-2</issue>
            <fpage>35</fpage>
            <page-range>35-42</page-range>
            <pub-id pub-id-type="pmid">19356853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Price</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Psychological and neural mechanisms of the affective dimension of pain.</article-title>
            <source>Science</source>
            <year>2000</year>
            <month>Jun</month>
            <day>09</day>
            <volume>288</volume>
            <issue>5472</issue>
            <fpage>1769</fpage>
            <page-range>1769-72</page-range>
            <pub-id pub-id-type="pmid">10846154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clark</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pennington</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pain assessment practices with nursing home residents.</article-title>
            <source>West J Nurs Res</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>26</volume>
            <issue>7</issue>
            <fpage>733</fpage>
            <page-range>733-50</page-range>
            <pub-id pub-id-type="pmid">15466611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>The relationship between surgical outcome and MMPI profiles in chronic pain patients.</article-title>
            <source>J Clin Psychol</source>
            <year>1981</year>
            <month>Oct</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>744</fpage>
            <page-range>744-9</page-range>
            <pub-id pub-id-type="pmid">6458625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>BECK</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>WARD</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>MENDELSON</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>MOCK</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>ERBAUGH</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>An inventory for measuring depression.</article-title>
            <source>Arch Gen Psychiatry</source>
            <year>1961</year>
            <month>Jun</month>
            <volume>4</volume>
            <fpage>561</fpage>
            <page-range>561-71</page-range>
            <pub-id pub-id-type="pmid">13688369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolf</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hawn</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Sanborn</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Todd</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Fein-Schaffer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Houranieh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>MMPI-2-RF Profiles of Treatment-Seeking Veterans in a VA Pain Clinic and Associations with Markers of Physical Performance.</article-title>
            <source>J Clin Psychol Med Settings</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-76</page-range>
            <pub-id pub-id-type="pmid">37418093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Albayrak</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Sa&#x000e7;mac&#x00131;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Albayrak</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Karaaslan</surname>
                <given-names>&#x000d6;</given-names>
              </name>
              <name>
                <surname>&#x00130;nan</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>A cross-sectional study on the personality traits of episodic and chronic migraine patients.</article-title>
            <source>Clin Neurol Neurosurg</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>227</volume>
            <fpage>107641</fpage>
            <pub-id pub-id-type="pmid">36871391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arnow</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Hunkeler</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Blasey</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Constantino</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Fireman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kraemer</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Dea</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hayward</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Comorbid depression, chronic pain, and disability in primary care.</article-title>
            <source>Psychosom Med</source>
            <year>2006</year>
            <season>Mar-Apr</season>
            <volume>68</volume>
            <issue>2</issue>
            <fpage>262</fpage>
            <page-range>262-8</page-range>
            <pub-id pub-id-type="pmid">16554392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Sousa</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Valverde</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Caramelo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Valverde</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Use of antidepressants in the treatment of chronic orofacial pain caused by temporomandibular disorders: A randomized controlled clinical trial.</article-title>
            <source>Med Clin (Barc)</source>
            <year>2024</year>
            <month>Jul</month>
            <day>26</day>
            <volume>163</volume>
            <issue>2</issue>
            <fpage>74</fpage>
            <page-range>74-77</page-range>
            <pub-id pub-id-type="pmid">38570297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fishbain</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Cole</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Does pain interfere with antidepressant depression treatment response and remission in patients with depression and pain? An evidence-based structured review.</article-title>
            <source>Pain Med</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>9</issue>
            <fpage>1522</fpage>
            <page-range>1522-39</page-range>
            <pub-id pub-id-type="pmid">25139618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mokhtari</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Irandoost</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sheikhbahaei</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Stress, pain, anxiety, and depression in endometriosis-Targeting glial activation and inflammation.</article-title>
            <source>Int Immunopharmacol</source>
            <year>2024</year>
            <month>May</month>
            <day>10</day>
            <volume>132</volume>
            <fpage>111942</fpage>
            <pub-id pub-id-type="pmid">38565045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turk</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Cahana</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Treatment of chronic non-cancer pain.</article-title>
            <source>Lancet</source>
            <year>2011</year>
            <month>Jun</month>
            <day>25</day>
            <volume>377</volume>
            <issue>9784</issue>
            <fpage>2226</fpage>
            <page-range>2226-35</page-range>
            <pub-id pub-id-type="pmid">21704872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chou</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Qaseem</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Snow</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Shekelle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Owens</surname>
                <given-names>DK</given-names>
              </name>
              <collab>Clinical Efficacy Assessment Subcommittee of the American College of Physicians</collab>
              <collab>American College of Physicians</collab>
              <collab>American Pain Society Low Back Pain Guidelines Panel</collab>
            </person-group>
            <article-title>Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society.</article-title>
            <source>Ann Intern Med</source>
            <year>2007</year>
            <month>Oct</month>
            <day>02</day>
            <volume>147</volume>
            <issue>7</issue>
            <fpage>478</fpage>
            <page-range>478-91</page-range>
            <pub-id pub-id-type="pmid">17909209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Doherty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leeb</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Alekseeva</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arden</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Bijlsma</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Din&#x000e7;er</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dziedzic</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>H&#x000e4;uselmann</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Herrero-Beaumont</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kaklamanis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lohmander</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maheu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n-Mola</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pavelka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Punzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reiter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sautner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smolen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Verbruggen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zimmermann-G&#x000f3;rska</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).</article-title>
            <source>Ann Rheum Dis</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>66</volume>
            <issue>3</issue>
            <fpage>377</fpage>
            <page-range>377-88</page-range>
            <pub-id pub-id-type="pmid">17046965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Moskowitz</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Nuki</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Abramson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Altman</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Arden</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bierma-Zeinstra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brandt</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Croft</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Doherty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dougados</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hochberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Kwoh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lohmander</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Tugwell</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.</article-title>
            <source>Osteoarthritis Cartilage</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-62</page-range>
            <pub-id pub-id-type="pmid">18279766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ide</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shoaibi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Patterns of Comorbidities and Prescribing and Dispensing of Non-steroidal Anti-inflammatory Drugs (NSAIDs) Among Patients with Osteoarthritis in the USA: Real-World Study.</article-title>
            <source>Drugs Aging</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>357</fpage>
            <page-range>357-366</page-range>
            <pub-id pub-id-type="pmid">38520626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bjordal</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ljunggren</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Klovning</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sl&#x000f8;rdal</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials.</article-title>
            <source>BMJ</source>
            <year>2004</year>
            <month>Dec</month>
            <day>04</day>
            <volume>329</volume>
            <issue>7478</issue>
            <fpage>1317</fpage>
            <pub-id pub-id-type="pmid">15561731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fendrick</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis.</article-title>
            <source>Osteopath Med Prim Care</source>
            <year>2009</year>
            <month>Jan</month>
            <day>06</day>
            <volume>3</volume>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">19126235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rasmussen-Barr</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Held</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Grooten</surname>
                <given-names>WJA</given-names>
              </name>
              <name>
                <surname>Roelofs</surname>
                <given-names>PDDM</given-names>
              </name>
              <name>
                <surname>Koes</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>van Tulder</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Wertli</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Nonsteroidal Anti-inflammatory Drugs for Sciatica: An Updated Cochrane Review.</article-title>
            <source>Spine (Phila Pa 1976)</source>
            <year>2017</year>
            <month>Apr</month>
            <day>15</day>
            <volume>42</volume>
            <issue>8</issue>
            <fpage>586</fpage>
            <page-range>586-594</page-range>
            <pub-id pub-id-type="pmid">28399072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dworkin</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Backonja</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Farrar</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Finnerup</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Kalso</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Loeser</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Miaskowski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nurmikko</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Portenoy</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>ASC</given-names>
              </name>
              <name>
                <surname>Stacey</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Treede</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Turk</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Pharmacologic management of neuropathic pain: evidence-based recommendations.</article-title>
            <source>Pain</source>
            <year>2007</year>
            <month>Dec</month>
            <day>05</day>
            <volume>132</volume>
            <issue>3</issue>
            <fpage>237</fpage>
            <page-range>237-251</page-range>
            <pub-id pub-id-type="pmid">17920770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McNicol</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Midbari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eisenberg</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Opioids for neuropathic pain.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2013</year>
            <month>Aug</month>
            <day>29</day>
            <volume>2013</volume>
            <issue>8</issue>
            <fpage>CD006146</fpage>
            <pub-id pub-id-type="pmid">23986501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coelho</surname>
                <given-names>DRA</given-names>
              </name>
              <name>
                <surname>Gersten</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Fregni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cassano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vieira</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>Treating neuropathic pain and comorbid affective disorders: Preclinical and clinical evidence.</article-title>
            <source>Pain Pract</source>
            <year>2024</year>
            <month>Apr</month>
            <day>04</day>
            <pub-id pub-id-type="pmid">38572653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Von Korff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kolodny</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Deyo</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Long-term opioid therapy reconsidered.</article-title>
            <source>Ann Intern Med</source>
            <year>2011</year>
            <month>Sep</month>
            <day>06</day>
            <volume>155</volume>
            <issue>5</issue>
            <fpage>325</fpage>
            <page-range>325-8</page-range>
            <pub-id pub-id-type="pmid">21893626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alarc&#x000e3;o</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fareleira</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vaz-Carneiro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Tapentadol for chronic musculoskeletal pain in adults.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>May</month>
            <day>27</day>
            <volume>2015</volume>
            <issue>5</issue>
            <fpage>CD009923</fpage>
            <pub-id pub-id-type="pmid">26017279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krebs</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Gravely</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nugent</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>DeRonne</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Goldsmith</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Kroenke</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bair</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Noorbaloochi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.</article-title>
            <source>JAMA</source>
            <year>2018</year>
            <month>Mar</month>
            <day>06</day>
            <volume>319</volume>
            <issue>9</issue>
            <fpage>872</fpage>
            <page-range>872-882</page-range>
            <pub-id pub-id-type="pmid">29509867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chou</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fanciullo</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ballantyne</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Donovan</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Fishbain</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Foley</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Fudin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gilson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Kelter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mauskop</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Passik</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Pasternak</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Portenoy</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Rich</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Todd</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Miaskowski</surname>
                <given-names>C</given-names>
              </name>
              <collab>American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel</collab>
            </person-group>
            <article-title>Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.</article-title>
            <source>J Pain</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-30</page-range>
            <pub-id pub-id-type="pmid">19187889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frieden</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Houry</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Reducing the Risks of Relief--The CDC Opioid-Prescribing Guideline.</article-title>
            <source>N Engl J Med</source>
            <year>2016</year>
            <month>Apr</month>
            <day>21</day>
            <volume>374</volume>
            <issue>16</issue>
            <fpage>1501</fpage>
            <page-range>1501-4</page-range>
            <pub-id pub-id-type="pmid">26977701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dublin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Shortreed</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ludman</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Thakral</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saunders</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Parchman</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Von Korff</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Impact of initiatives to reduce prescription opioid risks on medically attended injuries in people using chronic opioid therapy.</article-title>
            <source>Pharmacoepidemiol Drug Saf</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>90</fpage>
            <page-range>90-96</page-range>
            <pub-id pub-id-type="pmid">30375121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Von Korff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dublin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Parchman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shortreed</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Saunders</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid Therapy.</article-title>
            <source>J Pain</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-10</page-range>
            <pub-id pub-id-type="pmid">26476264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dowell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Haegerich</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2016</year>
            <month>Mar</month>
            <day>18</day>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-49</page-range>
            <pub-id pub-id-type="pmid">26987082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jung</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ilom&#x000e4;ki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Opioid characteristics and nonopioid interventions associated with successful opioid taper in patients with chronic noncancer pain.</article-title>
            <source>Pain</source>
            <year>2024</year>
            <month>Jun</month>
            <day>01</day>
            <volume>165</volume>
            <issue>6</issue>
            <fpage>1327</fpage>
            <page-range>1327-1335</page-range>
            <pub-id pub-id-type="pmid">38112755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Els</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Kunyk</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lappi</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Sonnenberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hagtvedt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kolahdooz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Straube</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Oct</month>
            <day>30</day>
            <volume>10</volume>
            <issue>10</issue>
            <fpage>CD012509</fpage>
            <pub-id pub-id-type="pmid">29084357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mallick-Searle</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Garofoli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Frontline Perspectives on Buprenorphine for the Management of Chronic Pain.</article-title>
            <source>J Multidiscip Healthc</source>
            <year>2024</year>
            <volume>17</volume>
            <fpage>1375</fpage>
            <page-range>1375-1383</page-range>
            <pub-id pub-id-type="pmid">38563040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Acampora</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Chronic opioid pain treatment converted to buprenorphine: A case series using a 3-step low-dose incremental dosing guideline.</article-title>
            <source>J Opioid Manag</source>
            <year>2024</year>
            <season>Jan-Feb</season>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-56</page-range>
            <pub-id pub-id-type="pmid">38533715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rattanavong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kwan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jorgenson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Landry</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marwah</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Halpape</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Low-dose Initiation of Buprenorphine/naloxone for the Management of Chronic Non-cancer Pain in Patients on Long-term Opioid Therapy: A Case Series.</article-title>
            <source>Can J Pain</source>
            <year>2024</year>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>2310811</fpage>
            <pub-id pub-id-type="pmid">38571889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freynhagen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of neuropathic pain.</article-title>
            <source>BMJ</source>
            <year>2009</year>
            <month>Aug</month>
            <day>12</day>
            <volume>339</volume>
            <fpage>b3002</fpage>
            <pub-id pub-id-type="pmid">19675082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilron</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Neuropathic pain: principles of diagnosis and treatment.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>90</volume>
            <issue>4</issue>
            <fpage>532</fpage>
            <page-range>532-45</page-range>
            <pub-id pub-id-type="pmid">25841257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finnerup</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Attal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Haroutounian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McNicol</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dworkin</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Gilron</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Haanp&#x000e4;&#x000e4;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hansson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Kamerman</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Lund</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raja</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Rowbotham</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sena</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Siddall</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.</article-title>
            <source>Lancet Neurol</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>162</fpage>
            <page-range>162-73</page-range>
            <pub-id pub-id-type="pmid">25575710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Albrecht</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Houk</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ruggiero</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Banov</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dockum</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Bassani</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous targets for topical pain medications in patients with neuropathic pain: individual differential expression of biomarkers supports the need for personalized medicine.</article-title>
            <source>Pain Rep</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>e1119</fpage>
            <pub-id pub-id-type="pmid">38375092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Derry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Straube</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wiffen</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Aldington</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Pregabalin for neuropathic pain in adults.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Jan</month>
            <day>23</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD007076</fpage>
            <pub-id pub-id-type="pmid">30673120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gronseth</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cruccu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Alksne</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Argoff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brainin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burchiel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nurmikko</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zakrzewska</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies.</article-title>
            <source>Neurology</source>
            <year>2008</year>
            <month>Oct</month>
            <day>07</day>
            <volume>71</volume>
            <issue>15</issue>
            <fpage>1183</fpage>
            <page-range>1183-90</page-range>
            <pub-id pub-id-type="pmid">18716236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiffen</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Derry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>McQuay</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Carbamazepine for acute and chronic pain in adults.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2011</year>
            <month>Jan</month>
            <day>19</day>
            <issue>1</issue>
            <fpage>CD005451</fpage>
            <pub-id pub-id-type="pmid">21249671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McQuay</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Tram&#x000e8;r</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nye</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wiffen</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of antidepressants in neuropathic pain.</article-title>
            <source>Pain</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>68</volume>
            <issue>2-3</issue>
            <fpage>217</fpage>
            <page-range>217-27</page-range>
            <pub-id pub-id-type="pmid">9121808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sindrup</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Finnerup</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Antidepressants in the treatment of neuropathic pain.</article-title>
            <source>Basic Clin Pharmacol Toxicol</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>96</volume>
            <issue>6</issue>
            <fpage>399</fpage>
            <page-range>399-409</page-range>
            <pub-id pub-id-type="pmid">15910402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaijankoski</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nissen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ik&#x000e4;heimo</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>von Und Zu Fraunberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Airaksinen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Huttunen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Neuropathic Pain Medication and Antidepressant Use after Disability Pension in Patients with Spinal Cord Stimulation for Persistent Spinal Pain Syndrome.</article-title>
            <source>Pain Res Manag</source>
            <year>2024</year>
            <volume>2024</volume>
            <fpage>4953758</fpage>
            <pub-id pub-id-type="pmid">38327724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <article-title>Duloxetine (Cymbalta) for diabetic neuropathic pain.</article-title>
            <source>Med Lett Drugs Ther</source>
            <year>2005</year>
            <month>Aug</month>
            <day>15-29</day>
            <volume>47</volume>
            <issue>1215-1216</issue>
            <fpage>67</fpage>
            <page-range>67-8</page-range>
            <pub-id pub-id-type="pmid">16103866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lunn</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wiffen</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Duloxetine for treating painful neuropathy or chronic pain.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2009</year>
            <month>Oct</month>
            <day>07</day>
            <issue>4</issue>
            <fpage>CD007115</fpage>
            <pub-id pub-id-type="pmid">19821395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aiyer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barkin</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Bhatia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Neuropathic Pain with Venlafaxine: A Systematic Review.</article-title>
            <source>Pain Med</source>
            <year>2017</year>
            <month>Oct</month>
            <day>01</day>
            <volume>18</volume>
            <issue>10</issue>
            <fpage>1999</fpage>
            <page-range>1999-2012</page-range>
            <pub-id pub-id-type="pmid">27837032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khaliq</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Alam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Puri</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Topical lidocaine for the treatment of postherpetic neuralgia.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2007</year>
            <month>Apr</month>
            <day>18</day>
            <issue>2</issue>
            <fpage>CD004846</fpage>
            <pub-id pub-id-type="pmid">17443559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Derry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wiffen</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Quinlan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Topical lidocaine for neuropathic pain in adults.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Jul</month>
            <day>24</day>
            <volume>2014</volume>
            <issue>7</issue>
            <fpage>CD010958</fpage>
            <pub-id pub-id-type="pmid">25058164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Massey</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Derry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>McQuay</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Topical NSAIDs for acute pain in adults.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2010</year>
            <month>Jun</month>
            <day>16</day>
            <issue>6</issue>
            <fpage>CD007402</fpage>
            <pub-id pub-id-type="pmid">20556778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haroutiunian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Drennan</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Lipman</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Topical NSAID therapy for musculoskeletal pain.</article-title>
            <source>Pain Med</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>535</fpage>
            <page-range>535-49</page-range>
            <pub-id pub-id-type="pmid">20210866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mason</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Derry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McQuay</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of topical capsaicin for the treatment of chronic pain.</article-title>
            <source>BMJ</source>
            <year>2004</year>
            <month>Apr</month>
            <day>24</day>
            <volume>328</volume>
            <issue>7446</issue>
            <fpage>991</fpage>
            <pub-id pub-id-type="pmid">15033881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hui</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Xong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.</article-title>
            <source>Pain Med</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>12</issue>
            <fpage>1827</fpage>
            <page-range>1827-33</page-range>
            <pub-id pub-id-type="pmid">21134121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nugent</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Morasco</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>O'Neil</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Elven</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zakher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Motu'apuaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Paynter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kansagara</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review.</article-title>
            <source>Ann Intern Med</source>
            <year>2017</year>
            <month>Sep</month>
            <day>05</day>
            <volume>167</volume>
            <issue>5</issue>
            <fpage>319</fpage>
            <page-range>319-331</page-range>
            <pub-id pub-id-type="pmid">28806817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martimbianco</surname>
                <given-names>ALC</given-names>
              </name>
              <name>
                <surname>Porf&#x000ed;rio</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Pacheco</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Torloni</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Riera</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Dec</month>
            <day>12</day>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>CD011927</fpage>
            <pub-id pub-id-type="pmid">31830313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cruccu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>TZ</given-names>
              </name>
              <name>
                <surname>Garcia-Larrea</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hansson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Lefaucheur</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>EFNS guidelines on neurostimulation therapy for neuropathic pain.</article-title>
            <source>Eur J Neurol</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>952</fpage>
            <page-range>952-70</page-range>
            <pub-id pub-id-type="pmid">17718686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>North</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Farrokhi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Piantadosi</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial.</article-title>
            <source>Neurosurgery</source>
            <year>2005</year>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <page-range>98-106; discussion 106-7</page-range>
            <pub-id pub-id-type="pmid">15617591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eldabe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Buchser</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management.</article-title>
            <source>Neuromodulation</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>201</fpage>
            <page-range>201-9</page-range>
            <pub-id pub-id-type="pmid">21992833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Vos</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zaalberg</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Nijhuis</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Duyvendak</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Vesper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Enggaard</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Lenders</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial.</article-title>
            <source>Pain</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>155</volume>
            <issue>11</issue>
            <fpage>2426</fpage>
            <page-range>2426-31</page-range>
            <pub-id pub-id-type="pmid">25180016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hunter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dav&#x000e9;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Diwan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Deer</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Neuromodulation of pelvic visceral pain: review of the literature and case series of potential novel targets for treatment.</article-title>
            <source>Pain Pract</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-17</page-range>
            <pub-id pub-id-type="pmid">22521096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kapural</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nagem</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tlucek</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sessler</surname>
                <given-names>DI</given-names>
              </name>
            </person-group>
            <article-title>Spinal cord stimulation for chronic visceral abdominal pain.</article-title>
            <source>Pain Med</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>347</fpage>
            <page-range>347-55</page-range>
            <pub-id pub-id-type="pmid">20088856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lamer</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Moeschler</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gazelka</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Hooten</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Bendel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Spinal Stimulation for the Treatment of Intractable Spine and Limb Pain: A Systematic Review of RCTs and Meta-Analysis.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>94</volume>
            <issue>8</issue>
            <fpage>1475</fpage>
            <page-range>1475-1487</page-range>
            <pub-id pub-id-type="pmid">31279543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Relationships between the Spinal Dural Pulsations and the Short-Term Efficacy of Lumbar Epidural Steroid Injection.</article-title>
            <source>Pain Res Manag</source>
            <year>2024</year>
            <volume>2024</volume>
            <fpage>1824269</fpage>
            <pub-id pub-id-type="pmid">38528984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sargut</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Tkatschenko</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fr&#x000fc;h</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>T&#x000fc;ttenberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Heckert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fleck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kuckuck</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bayerl</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Study protocol for a prospective, randomized, multicenter trial to investigate the influence of peripheral nerve stimulation on patients with chronic sacroiliac joint syndrome (SILENCING).</article-title>
            <source>Trials</source>
            <year>2024</year>
            <month>Mar</month>
            <day>28</day>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>223</fpage>
            <pub-id pub-id-type="pmid">38549128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farrar</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>LaMoreaux</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Werth</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Poole</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.</article-title>
            <source>Pain</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>94</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-158</page-range>
            <pub-id pub-id-type="pmid">11690728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kemler</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>de Vet</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Barendse</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>van den Wildenberg</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>van Kleef</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial.</article-title>
            <source>J Neurosurg</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>108</volume>
            <issue>2</issue>
            <fpage>292</fpage>
            <page-range>292-8</page-range>
            <pub-id pub-id-type="pmid">18240925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watkins</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Kaplowitz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Slattery</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Colonese</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Colucci</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.</article-title>
            <source>JAMA</source>
            <year>2006</year>
            <month>Jul</month>
            <day>05</day>
            <volume>296</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-93</page-range>
            <pub-id pub-id-type="pmid">16820551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holubek</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Kalman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.</article-title>
            <source>Hepatology</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>880; author reply 882</fpage>
            <pub-id pub-id-type="pmid">16557558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jalan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bernuau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Paracetamol: are therapeutic doses entirely safe?</article-title>
            <source>Lancet</source>
            <year>2006</year>
            <month>Dec</month>
            <day>23</day>
            <volume>368</volume>
            <issue>9554</issue>
            <fpage>2195</fpage>
            <page-range>2195-6</page-range>
            <pub-id pub-id-type="pmid">17189017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cavalcante</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Sprung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schroeder</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Weingarten</surname>
                <given-names>TN</given-names>
              </name>
            </person-group>
            <article-title>Multimodal Analgesic Therapy With Gabapentin and Its Association With Postoperative Respiratory Depression.</article-title>
            <source>Anesth Analg</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>125</volume>
            <issue>1</issue>
            <fpage>141</fpage>
            <page-range>141-146</page-range>
            <pub-id pub-id-type="pmid">27984223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gomes</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Greaves</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van den Brink</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Antoniou</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mamdani</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Paterson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Juurlink</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.</article-title>
            <source>Ann Intern Med</source>
            <year>2018</year>
            <month>Nov</month>
            <day>20</day>
            <volume>169</volume>
            <issue>10</issue>
            <fpage>732</fpage>
            <page-range>732-734</page-range>
            <pub-id pub-id-type="pmid">30140853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Silverman</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Manchikanti</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A comprehensive review of opioid-induced hyperalgesia.</article-title>
            <source>Pain Physician</source>
            <year>2011</year>
            <season>Mar-Apr</season>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-61</page-range>
            <pub-id pub-id-type="pmid">21412369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayek</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Veizi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hanes</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Treatment-Limiting Complications of Percutaneous Spinal Cord Stimulator Implants: A Review of Eight Years of Experience From an Academic Center Database.</article-title>
            <source>Neuromodulation</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>18</volume>
            <issue>7</issue>
            <fpage>603</fpage>
            <page-range>603-8; discussion 608-9</page-range>
            <pub-id pub-id-type="pmid">26053499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deer</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Mekhail</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Provenzano</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pope</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Krames</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Raso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>DeAndres</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Buchser</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Buvanendran</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liem</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rizvi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abejon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eldabe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hayek</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McDowell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Poree</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>McJunkin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kapural</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Foreman</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Caraway</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Narouze</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>North</surname>
                <given-names>R</given-names>
              </name>
              <collab>Neuromodulation Appropriateness Consensus Committee</collab>
            </person-group>
            <article-title>The appropriate use of neurostimulation: avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain. Neuromodulation Appropriateness Consensus Committee.</article-title>
            <source>Neuromodulation</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>571</fpage>
            <page-range>571-97; discussion 597-8</page-range>
            <pub-id pub-id-type="pmid">25112891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Buchser</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Linderoth</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Meglio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Van Buyten</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Avoiding complications from spinal cord stimulation: practical recommendations from an international panel of experts.</article-title>
            <source>Neuromodulation</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-33</page-range>
            <pub-id pub-id-type="pmid">22151809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Osborne</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Ghazi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Boone</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Sletten</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Nottmeier</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>Spinal cord stimulator--trial lead migration study.</article-title>
            <source>Pain Med</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-8</page-range>
            <pub-id pub-id-type="pmid">21143759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vallejo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Benyamin</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Neuromodulation of the cervical spinal cord in the treatment of chronic intractable neck and upper extremity pain: a case series and review of the literature.</article-title>
            <source>Pain Physician</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>305</fpage>
            <page-range>305-11</page-range>
            <pub-id pub-id-type="pmid">17387353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolter</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kieselbach</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Cervical spinal cord stimulation: an analysis of 23 patients with long-term follow-up.</article-title>
            <source>Pain Physician</source>
            <year>2012</year>
            <season>May-Jun</season>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>203</fpage>
            <page-range>203-12</page-range>
            <pub-id pub-id-type="pmid">22622904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>North</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Petrucci</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dorsi</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Spinal cord stimulation electrode design: a prospective, randomized, controlled trial comparing percutaneous with laminectomy electrodes: part II-clinical outcomes.</article-title>
            <source>Neurosurgery</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>990</fpage>
            <page-range>990-6; discussion 990-6</page-range>
            <pub-id pub-id-type="pmid">16284568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henderson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Schade</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Caraway</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Oakley</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Prevention of mechanical failures in implanted spinal cord stimulation systems.</article-title>
            <source>Neuromodulation</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>183</fpage>
            <page-range>183-91</page-range>
            <pub-id pub-id-type="pmid">22151706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bedder</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Bedder</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <article-title>Spinal cord stimulation surgical technique for the nonsurgically trained.</article-title>
            <source>Neuromodulation</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>12 Suppl 1</volume>
            <fpage>1</fpage>
            <page-range>1-19</page-range>
            <pub-id pub-id-type="pmid">22151467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rudiger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Infection rate of spinal cord stimulators after a screening trial period. A 53-month third party follow-up.</article-title>
            <source>Neuromodulation</source>
            <year>2011</year>
            <season>Mar-Apr</season>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>136</fpage>
            <page-range>136-41; discussion 141</page-range>
            <pub-id pub-id-type="pmid">21992200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cameron</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review.</article-title>
            <source>J Neurosurg</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>100</volume>
            <issue>3 Suppl Spine</issue>
            <fpage>254</fpage>
            <page-range>254-67</page-range>
            <pub-id pub-id-type="pmid">15029914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turnbull</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Shepherd</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Post-dural puncture headache: pathogenesis, prevention and treatment.</article-title>
            <source>Br J Anaesth</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>91</volume>
            <issue>5</issue>
            <fpage>718</fpage>
            <page-range>718-29</page-range>
            <pub-id pub-id-type="pmid">14570796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Costigan</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Sprigge</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Dural puncture: the patients' perspective. A patient survey of cases at a DGH maternity unit 1983-1993.</article-title>
            <source>Acta Anaesthesiol Scand</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>710</fpage>
            <page-range>710-4</page-range>
            <pub-id pub-id-type="pmid">8836266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19536.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petraglia</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Farber</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Gramer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Verla</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Parente</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lad</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>The Incidence of Spinal Cord Injury in Implantation of Percutaneous and Paddle Electrodes for Spinal Cord Stimulation.</article-title>
            <source>Neuromodulation</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>85</fpage>
            <page-range>85-90</page-range>
            <pub-id pub-id-type="pmid">26644210</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
